COVID-19

‘Pretty privilege’: attractive people considered more trustworthy, research confirms

Retrieved on: 
Wednesday, April 10, 2024

Beauty is not, as it is often assumed to be, “in the eye of the beholder” – but follows certain predictable rules.

Key Points: 
  • Beauty is not, as it is often assumed to be, “in the eye of the beholder” – but follows certain predictable rules.
  • The fascination for the perfect makeup or skincare is fired up by the impact of perfect faces displayed on social media and enhanced by image processing and filters.

Pretty privilege

  • Numerous studies have shown that attractive individuals benefit from a beauty bonus and earn higher salaries on average.
  • Beautiful individuals are consistently expected to be more intelligent and thought to be better leaders, which influences career trajectories and opportunities.

Does being attractive make you more trustworthy?

  • In our recent paper Adam Zylbersztejn, Zakaria Babutsidze, Nobuyuki Hanaki and I set out to find out.
  • Previous studies presented different portraits of individuals to observers and asked them about their beliefs about these people.
  • Each player’s payoff thus depended on their own actions and/or the actions of the other player:


If player A chooses “Left”, then regardless of player Bs’ choice:
If player A chooses “Right” and player B chooses “Don’t roll”:
If player A chooses “Right” and player B chooses “Roll”:

  • To do so they were presented with the abstract choice scenario explained above while individually sat in a cubicle.
  • If they decided not to trust, they were sure to receive a meagre 5-euro payout for their participation in the study.
  • However, once an A player decided to trust their B partner, their fate was in the B player’s hands.

Does gender come into play?

  • This implies that in our abstract economic exchange, beautiful individuals are more likely to benefit from the trust of others.
  • However, when investigating actual behaviour, we see that beautiful individuals are neither more nor less trustworthy than anyone else.
  • In other words, trustworthiness is driven by good old individual values and personality, which are not correlated with how someone looks.

Are beautiful people more suspicious of their peers?

  • However, we might wonder who is more likely to fall prey to this bias.
  • We constructed our study such that we could also investigate this question.
  • Specifically, the participants we recruited in Lyon to make their predictions also had their photos taken.
  • We thus knew how much they were influenced by the looks of others but also how conventionally good-looking they were themselves.


Astrid Hopfensitz ne travaille pas, ne conseille pas, ne possède pas de parts, ne reçoit pas de fonds d'une organisation qui pourrait tirer profit de cet article, et n'a déclaré aucune autre affiliation que son organisme de recherche.

From side hustles to sleeping streams: The truth behind the passive income hype

Retrieved on: 
Wednesday, April 10, 2024

Thousands of users regularly share their expertise, tips and advice for how their followers can, theoretically, achieve the same level of passive income without lifting a finger.

Key Points: 
  • Thousands of users regularly share their expertise, tips and advice for how their followers can, theoretically, achieve the same level of passive income without lifting a finger.
  • The passive income subreddit has nearly half a million members and the #passiveincome hashtag on TikTok has 1.2 million posts and billions of views.
  • Given the current state of the economy and governmental policy, it’s unsurprising that so many are lured by the appeal of passive income.

Earning while you sleep

  • They see influencers sharing their successes (and very rarely their failures) and are motivated to try their strategies out for themselves.
  • Various passive income subcultures have emerged, from finance bro hustle gurus to young women peddling money-making credit card schemes to their followers.
  • As research I conducted with sociologist Karen Gregory has shown, this has been further literalized by livestreamers on platforms like Twitch.
  • These streamers draw in more viewers and attention by livestreaming themselves sleeping, as fans donate money, promote their content and buy emojis or other perks throughout the broadcast.

Always be grinding

  • The idea of passive income is often glamorized, but the reality is that many of these ventures require significant effort.
  • Indeed, the understanding of what passive income is has transformed wildly, from what the Internal Revenue Service describes as “activities in which you don’t materially participate” to re-appropriating terms like “leveraged income” to refer to maintaining Airbnb rental properties as being somehow passive.
  • Some of it is surely good old-fashioned aspirational content and marketing, as journalist Rebecca Jennings wrote in a March 2023 article for Vox.
  • As a result, the concept of participating in multiple income streams to protect one’s self from financial vulnerability is re-framed as not only strategic but passive.
  • Sure, you can break up your labour into different entrepreneurial paths, but you can also, ideally, start them up and then let them go without much maintenance.

A new gilded age?

  • Only 20 per cent of Americans make passive income, and almost entirely via dividends, interest or rental properties (although whether rental properties count as truly passive income is still up for debate).
  • Canadian numbers are harder to come by, but Finance Canada estimated 83 per cent of taxable passive income was held by individuals in the top one per cent income range in 2017.
  • Nevertheless, in a new gilded age defined and structured by wealth that is passively inherited or transferred and rarely distributed, the rest of us can’t help but take notice of a platform economy waiting to be exploited — and why not?


Jake Pitre received funding from the Mitacs Globalink Research Award for portions of this research.

Biophytis announces its 2023 financial results and provides an update on its business activities

Retrieved on: 
Wednesday, April 10, 2024

2024: The actual start of the study will depend on the conclusion of partnership agreements and Biophytis' financial resources.

Key Points: 
  • 2024: The actual start of the study will depend on the conclusion of partnership agreements and Biophytis' financial resources.
  • Promising preclinical results for BIO101 (20-hydroxyecdysone) in obesity, suggesting beneficial metabolic effects on muscle and fat mass.
  • On this basis, Biophytis plans to start a phase 1/2 clinical trial in 2024, depending on its financial resources.
  • There is therefore significant doubt about the Company's ability to continue its business activities.

Biophytis announces its 2023 financial results and provides an update on its business activities

Retrieved on: 
Wednesday, April 10, 2024

2024: The actual start of the study will depend on the conclusion of partnership agreements and Biophytis' financial resources.

Key Points: 
  • 2024: The actual start of the study will depend on the conclusion of partnership agreements and Biophytis' financial resources.
  • Promising preclinical results for BIO101 (20-hydroxyecdysone) in obesity, suggesting beneficial metabolic effects on muscle and fat mass.
  • On this basis, Biophytis plans to start a phase 1/2 clinical trial in 2024, depending on its financial resources.
  • There is therefore significant doubt about the Company's ability to continue its business activities.

Modern Dental Group Announces 2023 Annual Results - Record High Revenue, EBITDA and Net Profit, Number of Cases Surpassing 2 Million

Retrieved on: 
Wednesday, April 10, 2024

The Board recommended a final dividend of HK9.0 cents per ordinary share for the year ended 31 December 2023.

Key Points: 
  • The Board recommended a final dividend of HK9.0 cents per ordinary share for the year ended 31 December 2023.
  • (26 March 2023, Hong Kong) Modern Dental Group Limited (“Modern Dental” or “the Group”, stock code: 03600.HK), a leading global dental prosthetic device provider, announces its annual results for the year ended December 31, 2023 (“the year”).
  • The Group is committed and will continue to equip ourselves to provide the state-of-the-art digital solutions offering to the dental community in the market.
  • The Group continues to grow into more than just a one-stop shop dental prosthetic provider, but a full dental ecosystem to support our customers.

EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges

Retrieved on: 
Wednesday, April 10, 2024

Grünwald, 28 March 2024 – Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals, today published its full Annual Report 2023.

Key Points: 
  • Grünwald, 28 March 2024 – Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals, today published its full Annual Report 2023.
  • Despite a difficult macroeconomic environment, Dermapharm succeeded in maintaining its growth trajectory and hitting the upper end of the guidance range in 2023.
  • "In addition to the end of the boom phase associated with vaccine production, 2023 was also shaped by various other macroeconomic and geopolitical challenges.
  • The Annual General Meeting of Dermapharm Holding SE will take place on 27 June 2024.

EQS-News: RHÖN-KLINIKUM AG looks back on successful financial year 2023

Retrieved on: 
Wednesday, April 10, 2024

RHÖN-KLINIKUM AG has met its financial targets as per forecast.

Key Points: 
  • RHÖN-KLINIKUM AG has met its financial targets as per forecast.
  • Earnings before interest, taxes, depreciation and amortisation (EBITDA) stood at 105.9 million euros (previous year: 105.6 million euros).
  • “In the past year as well, RHÖN-KLINIKUM AG demonstrated its financial efficiency and put in a solid performance.
  • RHÖN-KLINIKUM AG is looking to achieve CO2-greenhouse gas neutrality in Scope 1 and Scope 2 emissions by financial year 2040.

EQS-News: STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR

Retrieved on: 
Wednesday, April 10, 2024

For the 2024 financial year, STRATEC has planned investments in property, plant and equipment and in intangible assets corresponding to a total of 6.0% to 8.0% of sales (2023: 6.7%).

Key Points: 
  • For the 2024 financial year, STRATEC has planned investments in property, plant and equipment and in intangible assets corresponding to a total of 6.0% to 8.0% of sales (2023: 6.7%).
  • STRATEC made progress in numerous proprietary development projects and in its development cooperations with partners in the 2023 financial year.
  • Given the acquisition of Natech Plastics, Inc., the workforce of the STRATEC Group grew slightly in 2023.
  • To mark the publication of the definitive results for the 2023 financial year, we will be holding a conference call in English at 2.00 p.m. (CET) today, Thursday, March 28, 2024.

EQS-News: LUDWIG BECK with positive sales development in the 2023 fiscal year

Retrieved on: 
Wednesday, April 10, 2024

Munich, March 21, 2024 – Munich-based fashion group LUDWIG BECK (ISIN DE 0005199905) experienced a mixture of ups and downs in the 2023 fiscal year.

Key Points: 
  • Munich, March 21, 2024 – Munich-based fashion group LUDWIG BECK (ISIN DE 0005199905) experienced a mixture of ups and downs in the 2023 fiscal year.
  • Nevertheless, LUDWIG BECK managed to maintain sales at the previous year's level in the first half of the year.
  • In the 2023 fiscal year, LUDWIG BECK (including online) generated gross sales of € 86.5m (previous year: € 83.8m).
  • In the 2023 fiscal year, LUDWIG BECK AG generated net income of € 1.0m (previous year:
    € -0.6m).

EQS-News: SYNLAB delivers robust performance in FY 2023

Retrieved on: 
Wednesday, April 10, 2024

Synnovis, the South East London hospital outsourcing contract grew 12.2% in 2023 and contributed 0.6pts to the overall 2023 underlying organic growth.

Key Points: 
  • Synnovis, the South East London hospital outsourcing contract grew 12.2% in 2023 and contributed 0.6pts to the overall 2023 underlying organic growth.
  • FY 2023 adjusted EBITDA (AEBITDA) was €438 million (FY 2022: €753 million) while adjusted operating profit (AOP) was €194 million (FY 2022: €508 million) with margins of 16.6% (FY 2022: 23.2%) and 7.4% (FY 2022: 15.6%), respectively.
  • In FY 2023, adjusted net profit (Group share) was €44 million (FY 2022: €342 million), mainly due to lower COVID-19 testing volumes and higher net finance costs.
  • FY 2023 unlevered free cash flow (uFCF) was €74 million (FY 2022: €312 million).